To investigate the relationship between fasting and 2-h postprandial plasma glucose concentrations and vascular complications in type 2 diabetes. METHODS: Consecutive patients with type 2 diabetes admitted for blood glucose control were grouped according to their fasting and 2-h postprandial plasma glucose levels. Frequency and severity of diabetic retinopathy and nephropathy, number of carotid artery plaques, coefficient of variation of R-R intervals (CVRR), brachial-ankle pulse wave velocity (baPWV), intima-media thickness, brain natriuretic peptide level, ankle-brachial index, and high-sensitivity C-reactive protein levels were compared.
Introduction
Large clinical trials and epidemiological studies of patients with diabetes mellitus have shown that the onset and progression of diabetic microvascular complications can be prevented by strict blood glucose control. 1 -3 Additionally, although the relationship between blood glucose control and macrovascular diseases is not as robust as that for microvascular diseases, it has been shown that macrovascular diseases can be prevented, to some extent, by better blood glucose control in patients with diabetes mellitus. 4, 5 Reducing the glycosylated haemoglobin (HbA 1C ) level has been considered to be the most important target M Tanaka Fasting and postprandial glucose and type 2 diabetes complications for diabetes treatment, and much attention has been paid to lowering the fasting blood glucose concentration. 6 It has been shown, however, that lowering only the fasting plasma glucose level is insufficient for achieving excellent diabetes control; 7 the postprandial blood glucose concentration is as important as (or even more important than) the fasting plasma glucose concentration for the prevention of vascular complications in individuals with or without diabetes. 8 -10 Thus, the present study was conducted to investigate the relationship between the risk of vascular complications and fasting, and 2-h postprandial plasma glucose levels, in patients with type 2 diabetes mellitus.
Patients and methods

STUDY POPULATION
Consecutive patients with pre-existing type 2 diabetes mellitus and poorly controlled blood glucose, admitted to the Department of Internal Medicine, Keio University Hospital, Tokyo, Japan, between April 2008 and August 2010 with the aim of improving blood glucose control, were enrolled into this study.
Data and patient history were gathered retrospectively from patient records, but inclusion was conditional on the patients reading and signing informed consent forms. This study was approved by the Ethics Committee of Keio University Hospital. Patients were excluded if they were glutamic acid decarboxylase antibody positive, had abnormal aspartate aminotransferase/ alanine aminotransferase elevations (over three times the upper limit of normal) or had serum creatinine levels > 2.0 mg/dl. The diagnoses of hypertension, dyslipidaemia, cerebral infarction, coronary artery disease and peripheral artery disease were made from patients' histories. All assessments (described below) were undertaken on the day after, or 2 days after, hospital admission. All patients were receiving the ideal dietary calorie intake calculated for their body weight (i.e. height [m] 2 × 22 × 25 kcal/kg) when the assessments (including blood sampling) were undertaken.
ASSESSMENT OF FASTING AND POSTPRANDIAL PLASMA GLUCOSE
Fasting (overnight, no calorie intake for ≥ 8 h) and 2-h postprandial (2 h after breakfast) plasma glucose levels were measured in blood samples taken from the antecubital vein. For glucose assessment, 2 ml was collected directly into a standard tube; for the laboratory assessments, a further 8.5 ml was collected into tubes containing 1.8 mg/ml disodium ethylene diaminetetraacetate dihydrate and 1.1 mg/ml sodium fluoride. Blood samples were stored at 4°C for 1 -2 h prior to analysis. Assessments were performed using a glucose meter (Arkray Marketing, Tokyo, Japan) that used the amperometric method, involving glucose oxidase and hydrogen peroxide.
Patients were divided into three groups according to their fasting plasma glucose levels: low, 63 -121 mg/dl; medium, 122 -157 mg/dl; high, 158 -365 mg/dl. Subsequently, patients were divided into a further three groups according to their 2-h postprandial plasma glucose levels: low, 102 -207 mg/dl; medium, 208 -272 mg/dl; high, 273 -420 mg/dl.
ASSESSMENT OF DIABETIC RETINOPATHY
Frequency and severity of diabetic retinopathy was assessed by checking for pupil dilatation. These examinations were undertaken by ophthalmologists (not the study investigator), who were blinded to the patients' details. Diabetic retinopathy was classified as simple, preproliferative, or proliferative. Since the patient numbers with M Tanaka Fasting and postprandial glucose and type 2 diabetes complications preproliferative and proliferative retinopathy were relatively small, these categories were combined into 'proliferative retinopathy' for the analyses.
ASSESSMENT OF DIABETIC NEPHROPATHY
Diabetic nephropathy was evaluated according to the urinary albumin-tocreatinine ratio (ACR), measured using the first morning urine sample obtained from each patient. Urinary concentrations of albumin and creatinine were determined using a turbidimetric immunoassay with a Superior-Microalbumin kit (Daiichi Pharmaceutical Co., Tokyo, Japan) and with the Jaffé reaction, using an automated analyser. Diabetic nephropathy was classified into: without nephropathy, urinary ACR < 30 mg/g creatinine; microalbuminuria, urinary ACR ≥ 30 and < 300 mg/g creatinine; macroalbuminuria, urinary ACR ≥ 300 mg/g creatinine.
ASSESSMENT OF CAROTID ARTERY PLAQUES
Carotid artery plaques were assessed by ultrasonography B-mode imaging, using a PowerVision™ 6000 ultrasound machine (Toshiba, Tokyo, Japan) at a transducer frequency of 7.5 MHz. Carotid artery plaques were defined as the total number of localized, elevated lesions in the bilateral common carotid arteries, carotid sinus and internal carotid arteries.
CARDIAC ASSESSMENTS
The coefficient of variation of R-R interval (CVRR) was measured after 5 min of bed rest, and the mean value of two consecutive measures was adopted. Brachial-ankle pulse wave velocity (baPWV) was measured after 5 min of bed rest; the higher value for baPWV was adopted for analyses. Ankle-brachial index (ABI) was measured after 5 min of bed rest; the lower value for ABI of both sides was adopted for analysis. These parameters were measured using a BP-203RPE III (form PWV/ABI) device (Omron Healthcare, Kyoto, Japan).
Mean intima-media thickness (IMT) was measured using carotid ultrasonography Bmode imaging of the carotid artery, performed using the PowerVision™ 6000 (described above). The higher value of both sides was used for analysis.
LABORATORY ASSESSMENTS
Levels of brain natriuretic peptide (BNP), high-sensitivity C-reactive protein (hsCRP) and HbA 1C were measured using fasting blood samples, obtained in the early morning, as described above. The circulating BNP level was determined with a fluorescence enzyme immunoassay, using a monoclonal antibody (E-test, Tosoh II BNP; Tosoh, Tokyo, Japan). Plasma hsCRP was measured using a latex particle-enhanced immunoassay with the nephelometry method (LABOSPECT 008; Hitachi, Tokyo, Japan), using a hsCRP kit from Mitsubishi Chemical Medicine (Tokyo, Japan). HbA 1C was measured by high performance liquid chromatography (HLC-723 G8; Tosoh) and expressed as the National Glycohemoglobin Standardization Program (NGSP) value (%). The International Federation of Clinical Chemistry (IFCC) unit of HbA 1C (mmol/mol) was also calculated: (IFCC = [10.93 × NGSP] -23.50).
STATISTICAL ANALYSES
Results were expressed as mean ± SD. Statistical analyses were performed using the JMP ® statistical software package, version 6 (SAS Japan Institute, Tokyo, Japan) for Windows ® . Tukey's multiple comparison tests after analysis of variance were performed for comparisons of mean values M Tanaka Fasting and postprandial glucose and type 2 diabetes complications among the groups. Pearson's χ 2 -test was performed to compare the proportion of patients stratified by vascular complications (without retinopathy, simple retinopathy, proliferative retinopathy; without nephropathy, microalbuminuria, macroalbuminuria; without carotid plaque, with one carotid plaque, with two or more carotid plaques). The correlation between two variables was tested using Pearson's correlation coefficient. All statistical tests were two-sided with a 5% significance level.
Results
A total of 206 patients with type 2 diabetes mellitus were included in the study; their demographic and clinical characteristics are presented in Table 1 .
As shown in Table 2 , 84 patients (41%) had retinopathy, 80 (39%) had nephropathy and many had diabetic neuropathy, hypertension or dyslipidaemia. Diabetes was treated with insulin, sulphonylurea, biguanide, α-glucosidase inhibitor, pioglitazone or glinide therapy in 89, 83, 31, 48, 18 and seven patients, respectively; 28 patients did not take any diabetic medication and were managed by diet only. Table 3 shows the frequency and severity of vascular complications according to fasting plasma glucose levels. In the group with a high fasting plasma glucose level, the number of patients with proliferative retinopathy was significantly higher than that in the other two groups (P = 0.028). The frequency and severity of diabetic nephropathy and the number of carotid plaques did not differ significantly between the three groups. As shown in Table 4 , none of the clinical parameters differed significantly among the three groups when they were stratified by fasting plasma glucose levels.
There were no differences in the frequency or severity of diabetic retinopathy, diabetic nephropathy or the number of carotid plaques according to 2-h postprandial plasma glucose levels ( Table 5 ). As shown in Table 6 , CVRR in the high plasma glucose level group was significantly lower than that in the low group (P = 0.028), and baPWV in the medium group was significantly higher than that in the low group (P = 0.035). Other parameters showed no significant betweengroup differences.
There was a strong inverse correlation 
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Discussion
The present study demonstrated that patients with type 2 diabetes mellitus who had high fasting plasma glucose levels had a high frequency of proliferative diabetic retinopathy. Consequently, this finding suggests that the fasting plasma glucose level is related to the severity of diabetic retinopathy, which is in line with other 
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reports stating that patients with high fasting plasma glucose and HbA 1C levels were at high risk of diabetic retinopathy. 1 -3 It has also been reported, however, that having a high fasting plasma glucose level increases the risk of death in patients with acute coronary syndrome, 11 and that a high HbA 1C level increases the risk of onset and Data presented as mean ± SD.
No statistically significant between-group differences for any clinical parameter (P ≥ 0.05); Pearson's χ 2 test. CVRR, coefficient of variation of R-R intervals; baPWV, brachial-ankle pulse wave velocity; IMT, intima-media thickness; BNP, brain natriuretic peptide; ABI, ankle-brachial index; hsCRP, high-sensitivity C-reactive protein. Several reports state that diabetic retinopathy, which is one of the microangiopathies, is strongly related to macroangiopathy. The Atherosclerosis Risk in Communities Study showed that the presence of diabetic retinopathy boosted the risk of death from coronary heart disease 14 and the risk of ischaemic cerebral infarction, 15 in patients with type 2 diabetes mellitus. In addition, the presence and severity of diabetic retinopathy are risk factors for ischaemic heart disease and cerebral infarction in patients with type 1 diabetes mellitus. 16 A meta-analysis showed that, in patients with type 1 or type 2 diabetes mellitus, diabetic retinopathy increases the risk of cardiovascular events and all-cause mortality. 17 It is conceivable, therefore, that the relationship between diabetic retinopathy and macroangiopathy is robust, and that recognizing that patients with high fasting plasma glucose levels are at a high risk of both microvascular and macrovascular diseases is important.
The present study showed that patients with medium or high 2-h postprandial plasma glucose levels had higher baPWV and lower CVRR, respectively, than those with low 2-h levels. The former is an indicator of atherosclerosis and the latter of diabetic neuropathy, which is a microvascular disease. Here, again, a relationship between macro-and microvascular complications is suggested. The Diabetes Epidemiology Collaborative analysis Of Diagnostic criteria in Europe study 18 and the Diabetes Epidemiology Collaborative analysis Of Diagnostic criteria in Asia study 19 revealed that postprandial hyperglycaemia is an independent risk factor for macrovascular events. In these studies, 18, 19 the glucoseloaded 2-h postchallenge plasma glucose concentration was a superior predictive factor for all-cause mortality and onset of cardiovascular disease compared with the fasting plasma glucose concentration. It has 20, 21 When an additional analysis of the Action to Control Cardiovascular Risk in Diabetes study -which introduced the argument as to the rights and wrongs of intensive blood glucose control in patients with type 2 diabetes mellitus -was performed for patients with type 2 diabetes mellitus with cardiac autonomic dysfunction, the risk of death increased two-to threefold. 22 Considering that CVRR is an indicator of cardiac autonomic function, it is highly probable that patients with high 2-h postprandial plasma glucose levels have progressive atherosclerosis and cardiac autonomic dysfunction, and are at high risk of macrovascular diseases and all-cause death. Thus, in addition to trying to control the plasma glucose level, it is also important to control other risk factors for macrovascular angiopathy, such as hypertension and dyslipidaemia.
There were several limitations to the present study. First, no control group was included. Moreover, because blood glucose levels were based only on one single measurement, there may be bias in that the study recruited a group of patients who were admitted to hospital specifically in order to obtain better blood glucose control.
Observing good blood glucose control at more than one time point may be important for preventing the onset and aggravation of vascular complications, and for achieving continued health while maintaining a good quality of daily life. To test this hypothesis, further studies are needed.
In conclusion, the present study has shown that elevated plasma glucose levels, both fasting and 2-h postprandial, can be considered as risk factors for vascular complications in patients with type 2 diabetes mellitus.
